未登录
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏Discovery of a novel anti-osteoporotic agent from marine fungus-derived structurally diverse sirenins
Cai, Jian; Gao, Li; Wang, Yue; Zheng, Yuanteng; Lin, Xiuling; Zhou, Pingzheng; Chen, Chunmei; Liu, Kechun; Tang, Lan; Liu, Yonghong; Tan, Yanhui; Jin, Meng; Zhou, Xuefeng
分享
收藏A novel TWIK2 channel inhibitor binds at the bottom of the selectivity filter and protects against LPS-induced experimental endotoxemia in vivo
Zhi, Yuanxing; Wu, Xiaoyan; Chen, Yanshan; Chen, Xingyuan; Chen, Xiangyu; Luo, Hui; Yi, Xin; Lin, Xiuling; Ma, Liang; Chen, Yao; Cao, Ying; Li, Fengxian; Zhou, Pingzheng
分享
收藏The volume regulated anion channel VRAC regulates NLRP3 inflammasome by modulating itaconate efflux and mitochondria function
Wu, Xiaoyan; Yi, Xin; Zhao, Boxin; Zhi, Yuanxing; Xu, Ziwei; Cao, Ying; Cao, Xiong; Pang, Jianxin; Yung, Ken Kin Lam; Zhang, Shiqing; Liu, Shuwen; Zhou, Pingzheng
分享
收藏
分享
收藏Novel DCPIB analogs as dual inhibitors of VRAC/TREK1 channels reduced cGAS-STING mediated interferon responses
Zhi, Yuanxing; Liu, Jin; Kuang, Peihua; Zhang, Xin; Xu, Ziwei; Chen, Yanshan; Lin, Xiuling; Wu, Xiaoyan; Zhou, Pingzheng; Chen, Jianjun
分享
收藏Pharmacological inhibition of Kv1.3 channel impairs TLR3/4 activation and type I IFN response and confers protection against Listeria monocytogenes infection (vol 177, 106112, 2022)
Zhang, Xin; Lin, Xiuling; Luo, Hui; Zhi, Yuanxing; Yi, Xin; Wu, Xiaoyan; Duan, Wendi; Cao, Ying; Pang, Jianxin; Liu, Shuwen; Zhou, Pingzheng
分享
收藏Pharmacological inhibition of Kv1.3 channel impairs TLR3/4 activation and type I IFN response and confers protection against Listeria monocytogenes infection
Zhang, Xin; Lin, Xiulin; Luo, Hui; Zhi, Yuanxing; Yi, Xin; Wu, Xiaoyan; Duan, Wendi; Cao, Ying; Pang, Jianxin; Liu, Shuwen; Zhou, Pingzheng
分享
收藏Discovery of novel verinurad analogs as dual inhibitors of URAT1 and GLUT9 with improved Druggability for the treatment of hyperuricemia
Zhao, Zean; Liu, Jin; Kuang, Peihua; Luo, Jian; Surineni, Goverdhan; Cen, Xiaolin; Wu, Ting; Cao, Ying; Zhou, Pingzheng; Pang, Jianxin; Zhang, Qun; Chen, Jianjun
分享
收藏CDER167, a dual inhibitor of URAT1 and GLUT9, is a novel and potent uricosuric candidate for the treatment of hyperuricemia (vol 43, pg 121, 2022)
Zhao, Ze-an; Jiang, Yu; Chen, Yan-yu; Wu, Ting; Lan, Qun-sheng; Li, Yong-mei; Li, Lu; Yang, Yang; Lin, Cui-ting; Cao, Ying; Zhou, Ping-zheng; Guo, Jia-yin; Tian, Yuan-xin; Pang, Jian-xin
分享
收藏ML365 inhibits TWIK2 channel to block ATP-induced NLRP3 inflammasome
Wu, Xiao-yan; Lv, Jin-yan; Zhang, Shi-qing; Yi, Xin; Xu, Zi-wei; Zhi, Yuan-xing; Zhao, Bo-xin; Pang, Jian-xin; Yung, Ken Kin Lam; Liu, Shu-wen; Zhou, Ping-zheng
分享
收藏Apigenin ameliorates hyperuricemic nephropathy by inhibiting URAT1 and GLUT9 and relieving renal fibrosis via the Wnt/β-catenin pathway
Li, Yongmei; Zhao, Zean; Luo, Jian; Jiang, Yanqing; Li, Lu; Chen, Yanyu; Zhang, Leqi; Huang, Qinghua; Cao, Ying; Zhou, Pingzheng; Wu, Ting; Pang, Jianxin
分享
收藏CDER167, a dual inhibitor of URAT1 and GLUT9, is a novel and potent uricosuric candidate for the treatment of hyperuricemiaCDER167是URAT1和GLUT9的双重抑制剂,是治疗高尿酸血症的新型有效的尿酸候选药物。
Zhao, Ze An; Jiang, Yu; Chen, Yan-yu; Wu, Ting; Lan, Qun-sheng; Li, Yong-mei; Li, Lu; Yang, Yang; Lin, Cui-ting; Cao, Ying; Zhou, Ping-zheng; Guo, Jia-yin; Tian, Yuan-xin; Pang, Jian-xin
分享
收藏
分享
收藏